{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"IDH1, a cell metabolism enzyme, is recurrently mutated in various cancer types including acute myeloid leukemia and gliomas.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"02/04/2019",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "21996744"
      ]
    },
    "description":"The IDH1 R49C mutation is a rare alteration that does not produce an increase in D-2-hydroxyglutarate (2-HG) levels, but also fails to increase isocitrate-dependent NADPH production. The former suggest that the IDH1 R49C mutation results in a decrease of the enzyme wildtype activity, without an increase in 2-HG oncometabolite generation (PMID: 21996744).",
    "knownEffect":"Loss-of-function"
  },
  "oncogenic":"Likely Neutral",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"R49C",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":3417,
    "hgvs":null,
    "hugoSymbol":"IDH1",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The IDH1 R49C mutation is likely neutral.",
  "vus":false
}